Jessica Bridoux studied Engineering Chemistry at the National Engineering School of Caen (Ecole Nationale Supérieure des Ingénieurs de Caen, ENSICAEN, Caen, France) where she graduated with distinctions and international mention in 2016. Simultaneously with the last year of her engineering studies, she obtained a Master diploma in Organic Chemistry. She gained experience in fluorine chemistry during a 4-month internship at the Institute of chemistry, Münster, Germany in the group of Prof. Dr. Haufe. As her final project, she worked 6 months in a company, PCAS, Limay, France, under the supervision of Dr. Marrec, in the research and development department, where she developed and optimized the synthesis process of an active pharmaceutical ingredient and learned about GMP manufacturing.
In October 2016, Jessica started her PhD project funded by the Horizon 2020 Marie Curie Actions (PET3D) in the In Vivo Cellular and Molecular Imaging (ICMI) laboratory, under the supervision of Prof. Dr. Catarina Xavier and Prof. Dr. Vicky Caveliers, working on the development of a site-specifically radiolabelled Nanobody against the human PD-L1 receptor for PET immune-imaging. In the frame of this project, she spent 2 months at the Karolinska Institute, Stockholm, Sweden, in collaboration with AstraZeneca Goteborg, Sweden, under the supervision of Dr. Magnus Schou and Dr. Chad Elmore, where she focused on click-chemistry mediated radiofluorinations.